Pharmaceutical Chemistry

Avinash Rangaraju

Bombay College of Pharmacy - Pharmaceutical Chemistry Department: Faculty profile picture

Name of the Faculty: Mr. Avinash Rangaraju

Designation: Assistant Professor

Qualification: M. Pharm.

Teaching Experience (Years): 16 years

Email:avinash.rangaraju@bcp.edu.in

Specialization / Area of Expertise:Synthesis of small molecules for antitubercular treatment, NIRF Nodal Officer and as Faculty Advisor in ACS-BCP student chapter.

Professional Overview :

Mr. Avinash Rangaraju serves as an Assistant Professor in the Department of Pharmaceutical Chemistry at Bombay College of Pharmacy. With a strong foundation in pharmaceutical sciences and a commitment to academic excellence, he contributes to teaching, research, and institutional development.

Academic Appointments

  • Avinash plays an active role in curriculum development, aligning syllabi with Choice-Based Credit System (CBCS) and emerging trends in pharmaceutical sciences.
  • He contributes to examination committees, internal quality audits, and NAAC documentation, ensuring compliance with the University of Mumbai and AICTE norms.
  • His leadership extends to organizing faculty development programs (FDPs) and skill enhancement workshops, fostering a culture of continuous learning

Research Interests and Contributions

  • Primary focus on synthetic medicinal chemistry, including design and evaluation of antibacterial, antitubercular, antioxidant, and wound-healing agents.
  • Synthesis, characterization and biological screening of heterocyclic compounds of therapeutic Interest.

Research Interests and Contributions

  • Google Scholar:
    • Total citations: 25
    • h-index: 3
    • i10-index: 1.
  • Notable Publications:
    • Sustainable dressings for wound healing (Biotechnology for Sustainable Materials, 2025) - 10 citations.
    • Isatin derivative studies (Medicinal Chemistry Research, 2012) - 8 citations.
    • Novel indole-dione antimycobacterial agents (Int. J. Adv. Pharm. Biol. Chem, 2013) - 7 citations.
    • Recent antioxidant Schiff-base series (EPRA IJRD, 2025).

Research Grants and Collaborations

  • Publishes collaboratively, indicating active research networks with colleagues (e.g., K. Murali, P. Ambre).

Societal Impact and Community Engagement

  • Through ACS-BCP student chapter, organizes knowledge-sharing events (e.g., seminars on drug discovery).
  • Encourages student involvement in science outreach and interactive discussions.

Innovation, Patents, and Digital Health Initiatives

  • No patent filings or formal digital-health initiatives found in public domains.
  • Demonstrates innovation in academic research—designing bioactive compounds and proposing synthetic methods—but no registered IP.

Mentorship, Awards, and Recognitions

  • Mentors ACS-BCP Student Chapter activities and guides students in scholarly events.
  • No formal awards or recognitions recorded in available online profiles.

Professional Memberships and Editorial Roles

  • Active with American Chemical Society, serving as Faculty Advisor for its BCP chapter.
  • No listings found for editorial board roles or other society memberships.

Recent Publications: (Best Five in last five years)

Sr. No.Publication TitleAuthor(s)Journal / Conference NameYear of PublicationVolume / Issue / Page NosType (Journal, Conference, Book Chapter, Patent, etc.)
1Sustainable Dressings for Wound HealingMunishwar Nath Gupta, Premlata Ambre and Avinash RangarajuBiotechnology for Sustainable MaterialsJan-25Vol. 21Journal
2A comprehensive review on Management of Hashimoto's disease using Dietary Approaches comparative Analysis Saracitinib, Nilotinib and dasatinib based on their safety, efficacy and tolerability in treating Alzheimer's disease.Hasan Ali Javed Badshah*, Mohamed Sami Najmuddin Ravuthar, Alfaz Pathan and Avinash RangarajuWorld Journal of Pharmaceutical ResearchNov-24Journal
3comparaitive Analysis Saracitinib, Nilotinib and dasatinib based on their safety, efficacy and tolerability in treating Alzheimers disease.Dhairya Arun Bheda, Pranjali Dinesh Pawar, Avinash Rangaraju, Abhishek RathodWorld Journal of Pharmaceutical ResearchOct-24Journal